Sarepta misses on the bottom line but raises lower end of 2026 revenue guidance

The Quick Take
Read the full report from the original publisher.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents.
Related
Markets
10x Genomics forecasts $625M-$635M 2026 revenue as it targets ~50 Atera shipments by year-end
Markets
Oxford Lane outlines $0.10 monthly distributions through March 2027 as it plans to redeem remaining $40M of 5% notes
Markets
NuScale signals shift to physical production with Doosan as it maintains $1.9B liquidity
Markets
